Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Simulations Plus Acquires Immunetrics For $15.5 Million
Simulations Plus, Inc. announced on June 20 that it acquired Immunetrics, Inc. Simulations Plus agreed to pay the shareholders of Immunetrics cash consideration of $15.5 million. This includes a $1.8 million hold-back, plus two future earn-out payments in the aggregate amount of up to $8 million based on the revenue performance of Immunetrics through December 31, 2024. Immunetrics has served major pharmaceutical companies with predictive-modeling solutions to support the design of clinical trials. Immunetrics’ technology includes a broad and continually expanding library of standardized disease progression models, as well as Thales, a comprehensive quantitative systems pharmacology... Read More »
The IMA Group Acquires Accelemed Research Institute in Second Move of the Year
The IMA Group on April 11 announced that it entered into an agreement to acquire Accelemed Research Institute. The acquisition expands The IMA Group’s depth in multi-therapeutic clinical trial sites focused on cardiometabolic and GI diseases such as non-alcoholic steatohepatitis, obesity, high cholesterol and diabetes. The financial terms were not disclosed. Accelemed Research Institute operates out of Austin, Texas and conducts clinical trials to allow safety and efficacy data to be collected for new drugs, medical devices or treatment techniques. The IMA Group provides government workers with medical, psychological and related evaluations, as well as ancillary services.... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
